Company intelligence / Profile preview

MEDx Translational Medicine

Ownership: Private
Development stage: Commercial

Overview

MEDx is a leading provider of integrated solutions in companion diagnostics and precision medicine in China. It offers a broad range of IVD/CDx products for oncology clinical trials and commercialization. The company collaborates with hundreds of pharmaceutical companies to support biomarker discovery, target validation, molecular testing, patient stratification, and clinical trial support.

Therapeutic areas: Oncology
Modalities: Diagnostic testMolecular testing
Industry: Molecular Diagnostics

Partnerships

Collaborates with hundreds of world-renowned pharmaceutical companies

Beyond the preview

Go deeper on MEDx Translational Medicine.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MEDx Translational Medicine.

Explore the full profile